<DOC>
	<DOCNO>NCT01484197</DOCNO>
	<brief_summary>This study ass pharmacodynamics , safety , tolerability pharmacokinetics two different formulation indacaterol maleate , administer via Concept1 device . The study aim determine whether novel formulation similar clinical profile establish formulation .</brief_summary>
	<brief_title>A Study Evaluate Effects Indacaterol Maleate New Formulation Concept 1 Device</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<criteria>Male female patient asthma Aged 18 Patients use inhale corticosteroid ( without long act beta agonist ) Patients demonstrate increase FEV1 inhale short act beta agonist Asthma exacerbations previous 6 month COPD pulmonary disease Excessive use short act beta agonist</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Indacaterol</keyword>
	<keyword>QAB149</keyword>
</DOC>